Profil
Naomi Hunder worked as Vice President-Clinical Development at Seagen Inc. from 2010 to 2017.
She then worked as VP-Clinical Development & Medical Affairs at Acerta Pharma BV from 2017 to 2019.
Her most recent job was as Chief Medical Officer at Silverback Therapeutics, Inc. Dr. Hunder received her undergraduate degree from Carleton College in 1992 and her doctorate degree from Sidney Kimmel Medical College in 1998.
Anciens postes connus de Naomi Hunder
| Sociétés | Poste | Fin |
|---|---|---|
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Chief Tech/Sci/R&D Officer | 01/01/2019 |
| SEAGEN INC. | Chief Tech/Sci/R&D Officer | 01/02/2017 |
| ARS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Naomi Hunder
| Carleton College | Undergraduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Health Technology |
Silverback Therapeutics, Inc.
 Silverback Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA. | Health Technology |
